trial · primary record
Biopsy Procedure
Metastatic Dedifferentiated Liposarcoma
| Phase | Phase 1 |
|---|---|
| Status | RECRUITING |
| Sponsor | Unknown |
| Enrolment | 30 |
| Primary completion | 2026-11-03 |
| Primary endpoint | Dose limiting toxicity (DLT) rate |
| Registry ID | NCT05711615 |
Provenance
- Source: ClinicalTrials.gov
- Fetched at: 2026-10-28T13:40:17.729Z
- Licence class: attribution-required
- Verdict: primary-source
- Entity id: NCT05711615
This record is rendered from the AEaH spine. If the source is unreachable the page is not generated.
Same entity, elsewhere in the suite
- Biopsy Procedure · compound